Department of Otolaryngology-Head and Neck Surgery, National University Hospital, Singapore, Singapore.
Department of Pathology, National University Hospital, Singapore, Singapore.
Eur Arch Otorhinolaryngol. 2021 Jul;278(7):2461-2471. doi: 10.1007/s00405-020-06329-5. Epub 2020 Sep 8.
Consistent prognosticators are needed to guide adjuvant treatment in tongue squamous cell carcinoma (SCC). We validate the prognostic significance of histopathologic parameters in surgically treated tongue SCC.
Archival specimens of 88 consecutive patients who were treated surgically for tongue SCC from 2003 to 2016 were re-analyzed by one pathologist. Patient records were retrospectively reviewed. Prognosticators of recurrence-free survival (RFS), overall survival (OS), and disease-specific survival (DSS) were identified using multivariate analysis.
Tumor depth of invasion (DOI) > 6 mm (OR 4.76; 95%CI 1.22-18.5; p = 0.024) and lymphovascular invasion (OR 5.61; 95%CI 1.00-31.5; p = 0.05) were independent predictors of nodal metastases. The overall 5-year RFS, OS and DSS were 70%, 82% and 84% respectively. Positive margins predicted poor RFS (HR 3.91; 95%CI 1.58-9.65; p = 0.003) and local recurrence-free survival (HR 4.96; 95%CI 1.36-18; p = 0.015). Presence of nodal metastases (HR 5.03; 95%CI 1.73-14.6; p = 0.003), tumor DOI > 6 mm (HR 9.91; 95%CI 1.26-78.0; p = 0.029) and positive margins (HR 8.26; 95%CI 2.75-24.8; p < 0.001) were independent predictors of poor OS. Presence of nodal metastases (HR 3.87; 95%CI 1.17-12.8; p = 0.027) and positive margins (HR 12.3; 95%CI 3.54-42.9; p < 0.001) also independently predicted poor DSS.
Margins' status was the only independent predictor of local recurrence. Tumor DOI, nodal and margin status were key prognosticators of survival and may determine the necessity for adjuvant therapy.
需要一致的预后指标来指导舌鳞状细胞癌(SCC)的辅助治疗。我们验证了组织病理学参数在手术治疗的舌 SCC 中的预后意义。
对 2003 年至 2016 年期间接受手术治疗的 88 例连续舌 SCC 患者的存档标本进行了一位病理学家的重新分析。回顾性审查患者记录。使用多变量分析确定无复发生存(RFS)、总生存(OS)和疾病特异性生存(DSS)的预后指标。
肿瘤浸润深度(DOI)>6mm(OR 4.76;95%CI 1.22-18.5;p=0.024)和淋巴血管侵犯(OR 5.61;95%CI 1.00-31.5;p=0.05)是淋巴结转移的独立预测因子。总的 5 年 RFS、OS 和 DSS 分别为 70%、82%和 84%。阳性切缘预测 RFS 不良(HR 3.91;95%CI 1.58-9.65;p=0.003)和局部无复发生存(HR 4.96;95%CI 1.36-18;p=0.015)。淋巴结转移(HR 5.03;95%CI 1.73-14.6;p=0.003)、肿瘤 DOI>6mm(HR 9.91;95%CI 1.26-78.0;p=0.029)和阳性切缘(HR 8.26;95%CI 2.75-24.8;p<0.001)是 OS 不良的独立预测因子。淋巴结转移(HR 3.87;95%CI 1.17-12.8;p=0.027)和阳性切缘(HR 12.3;95%CI 3.54-42.9;p<0.001)也独立预测了 DSS 不良。
切缘状态是局部复发的唯一独立预测因子。肿瘤 DOI、淋巴结和切缘状态是生存的关键预后因素,可能决定辅助治疗的必要性。